Suchergebnisse - "Merz, Valeria"

PubPharm (42)

1

Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma

enthalten in: Cancer research | 2024

von Pietrobono, S. | Sabbadini, F. | Bertolini, M. | +12

2

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer : try to do not think about the white bear

enthalten in: Therapeutic advances in medical oncology | 2024

von Melisi, D. | Casalino, S. | Pietrobono, S. | +3

3

Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma : The open-label, multicenter, phase II nITRO trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Melisi, D. | Zecchetto, C. | Merz, V. | +25

4

YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer

enthalten in: Journal of personalized medicine | 2023

von Bencivenga, M. | Torroni, L. | Dal Cero, M. | +13

5

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

enthalten in: Cancer medicine | 2023

von Procaccio, L. | Merz, V. | Fasano, M. | +21

6

Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab

enthalten in: Journal of personalized medicine | 2023

von Zecchetto, C. | Quinzii, A. | Casalino, S. | +12

7

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Nature medicine | 2023

von van de Haar, J. | Ma, X. | Ooft, S. | +47

CommentIn: Nat Rev Gastroenterol Hepatol. 2023 May;20(5):269. - PMID 37012321

8

Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer : A Multicenter Real-World Study

enthalten in: Medicina (Kaunas, Lithuania) | 2022

von Rizzo, A. | Salati, M. | Frega, G. | +15

9

Multicentre match-paired analysis of advanced biliary cancer long-term survivors : The BILONG study

enthalten in: Clinics and research in hepatology and gastroenterology | 2022

von Caputo, F. | Gelsomino, F. | Spallanzani, A. | +12

10

Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer : Two Case Reports

enthalten in: Clinical drug investigation | 2022

von Quinzii, A. | Zecchetto, C. | Casalino, S. | +7

1
2
3
4
5
Nächster »
[5]